3,108 press releases indexed under healthcare.
XERF, the dual-frequency skin tightening technology that has transformed aesthetics practices in the US and Asia-Pacific, is now available across EMEA. It arrives as new consumer research reveals a spike in demand for non-invasive rejuvenation. XERF arrives in Europe following strong...
Healthcare AI, portfolio operations company KHAI Ventures has entered into a strategic distribution agreement with Wellytics Health, a healthcare technology and AI company. Under the agreement, KHAI Ventures secures unrestricted commercial and research rights to utilize, enhance, market,...
VERAXA Biotech initiates a collaboration with Ardigen SA to optimize cancer target pair selection for growing BiTAC® pipeline.
Monday 13 July, 2026 Cor Hutton has two prosthetic legs, two transplanted hands, one third of a lung and a recent kidney transplant. This August she's driving a clapped-out Audi TT to Nice. She built Scotland's amputee charity because the support she needed didn't exist. Now she's driving to fund it. Sepsis took both of Cor Hutton's hands and both of her feet. Her family never left her side. But when she looked for someone who truly understood what she was living through, she couldn't find them. So, she built Finding Your Feet. Today, Finding Your Feet (FYF) is Scotland's only nationwide charity supporting amputees, those born without limbs, and their families. It offers peer support, counselling, well-being services and inclusive clubs and activities, the kind of community that Cor needed
PRINCETON, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced positive topline data from its Phase 4, open-label, single-arm SYNCHRONICITY clinical trial of Fluocinolone Acetonide Intravitreal Implant in patients with chronic non-infectious uveitis affecting the posterior segment of the eye (chronic NIU-PS).
New app functions empower patients, caregivers and health care professionals to easily find and access Karmanos' large portfolio of innovative cancer treatment options through actively recruiting clinical trials DETROIT, July 13, 2026 /PRNewswire/ -- The Barbara Ann Karmanos Cancer...
(PR-inside.com) Expansion Scales U.S. Single-Use Drug Substance Capacity to 20,000 Liters Across Two FDA-Registered Facilities SAN DIEGO, CA / ACCESS Newswire / July 13, 2026 / Bora Biologics, a U.S.-based biologics CDMO engineered for licensed supply, today announced the expansion of its U.S. drug substance manufacturing platform through the addition of the Rockville, Maryland site. The addition strengthens the company's U.S.-anchored BioSecure commercial platform and reinforces its long-term investment in domestic biologics manufacturing. With the addition of Rockville, Bora Biologics scales its total offering of installed U.S. single-use bioreactor capacity to 20,000 liters - scalable to 30,000 liters - across two FDA-registered facilities ..
Expansion Scales U.S. Single-Use Drug Substance Capacity to 20,000 Liters Across Two FDA-Registered Facilities
Experienced revenue cycle executive joins to unify One Mnet Health's software and services under one commercial strategy. ALISO VIEJO, Calif., July 13, 2026 /PRNewswire-PRWeb/ -- One Mnet Health, a leading healthcare technology and patient billing company that serves hospitals, ASCs, and...
Michael Davis has completed a new book, "The Cure: Magic Mushroom Therapy to Heal Mankind Mentally" — a captivating exploration of the transformative power of psilocybin, the active compound in magic mushrooms. Drawing on his own personal experiences, Davis makes a compelling case for embracing this ancient natural remedy to address the mental health crisis plaguing our nation. Author Michael Davis was [PR.com]
Report highlights clean energy, innovation and ESG recognition ZIBO, China, July 13, 2026 /PRNewswire/ -- INTCO Medical ("the Company"), a leading global manufacturer of disposable gloves, has released its 2025 Environmental, Social and Governance (ESG) Report, outlining progress in...
CARACAS, VENEZUELA - July 13, 2026 ( NEWMEDIAWIRE ) - LataMed AI Corp. (OTC: LMED) (the “Company”), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, today announced that management has begun planning for the Company's anticipated attendance at the World Health Expo 2027 in Dubai, United Arab Emirates, as part of its broader strategy to evaluate international healthcare expansion opportunities. Management believes attendance at World Health Expo 2027 will provide an important opportunity to engage with healthcare leaders, technology innovators, healthcare providers, government representatives, and potential strategic partners from around the worl